Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7589161 - Nanoparticle composition for quenching steel
The hardening of steel requires a step of rapid cooling performed by a variety of liquid solutions such as water-based or oil-based compositions. Water solutions are easy to dispose of and inexpensive but can result in too rapid cooling which leads to strained microstructures in the steel. Oil-based solutions provide slower cooling but are more expensive and can be dangerous. This patent from the Industrial Technology Research Institute teaches an alternative based on inorganic nanoparticles providing for an optimization of the desired qualities for steel quenching. Claim 1 reads:
1. A polymeric quenchant, comprising:
an inorganic nanoparticle,
a water-soluble polymer, and
water,
wherein a weight ratio of the inorganic nanoparticle, water-soluble polymer and water is about 0.05-5:1-5:100, and the inorganic nanoparticle is talc, smectite clay, vermiculite, halloysite, sericite, saponite, montmorillonite, beidellite, nontronite, mica, hectorite, or a combination thereof.
Full post as published by TinytechIP on September 17, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Retired Steel Workers Win Pension Benefits Class Action for $51 Million
Retired Steel Workers Win Pension Benefits Class Action for $51 Million
US Steel
Settles Class Action for $4.4 Million

Swedish Law Company Reorganisation Compulsory Composition
Patent Licenses Include Inherent Rights Allowing Third-Party Manufacture
Ortho-McNeil Pharmaceutical, Inc. v. Teva Pharmaceuticals Industries, Ltd. (Fed. Cir. 2009)
Restricted-Out Claims Not Eligible for Priority in Later CIP Application









